Citation Impact

Citing Papers

The Prevalence, Severity, and Distribution of Childhood Food Allergy in the United States
2011 Standout
The Pseudomonas aeruginosa accessory genome elements influence virulence towards Caenorhabditis elegans
2019 StandoutNobel
Pseudomonas aeruginosa manipulates redox and iron homeostasis of its microbiota partner Aspergillus fumigatus via phenazines
2015
Nucleoside-modified mRNA vaccination partially overcomes maternal antibody inhibition of de novo immune responses in mice
2020 StandoutNobel
From stress to inflammation and major depressive disorder: A social signal transduction theory of depression.
2014 Standout
A bacterial pathogen induces developmental slowing by high reactive oxygen species and mitochondrial dysfunction in Caenorhabditis elegans
2023 StandoutNobel
Targeting microbial biofilms: current and prospective therapeutic strategies
2017 Standout
Interventions for the eradication of methicillin-resistantStaphylococcus aureus(MRSA) in people with cystic fibrosis
2013
Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508delCFTR
2015 Standout
Partial Anomalous Pulmonary Venous Connection: Diagnosis by Transesophageal Echocardiography
1997
Atopic dermatitis
2003 Standout
Cystic fibrosis
2016 Standout
Global burden of childhood pneumonia and diarrhoea
2013 Standout
Pancreatic enzyme replacement therapy for people with cystic fibrosis
2014
Diffuse progressive pulmonary interstitial and intra-alveolar cholesterol granulomas in childhood
1996 StandoutNobel
Managing Cystic Fibrosis
2011
Atopic dermatitis
2015 Standout
The pathology of fungal infection and colonization in patients with cystic fibrosis
1989
The Otolaryngologic Manifestations of Gastroesophageal Reflux Disease (GERD): A Clinical Investigation of 225 Patients Using Ambulatory 24‐Hour pH Monitoring and an Experimental Investigation of the Role of Acid and Pepsin in the Development of Laryngeal Injury
1991 Standout
Cystic Fibrosis Pulmonary Guidelines
2007
Lung clearance index: Evidence for use in clinical trials in cystic fibrosis
2013
Diagnosing and Managing Common Food Allergies
2010
Ivacaftor potentiation of multiple CFTR channels with gating mutations
2012
Pseudomonas aeruginosa Exhibits Frequent Recombination, but Only a Limited Association between Genotype and Ecological Setting
2012
Calling All Hosts: Bacterial Communication In Situ
2017
Pharmacotherapy of impaired mucociliary clearance in non‐CF pediatric lung disease. A review of the literature
2007
Asthma
2017 Standout
Population-based study of lymphoma in Germany: rationale, study design and first results
2004
Resurgence of tuberculosis in children
1992 Standout
A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation
2011 Standout
Raised interleukin-17 is immunolocalised to neutrophils in cystic fibrosis lung disease
2010
High prevalence in cystic fibrosis patients of multiresistant hospital-acquired methicillin-resistant Staphylococcus aureus ST228-SCCmecI capable of biofilm formation
2008
Pharmacological treatment of severe, therapy-resistant asthma in children: what can we learn from where?
2011
Metazoan MicroRNAs
2018 Standout
New pharmacological approaches for cystic fibrosis: Promises, progress, pitfalls
2014
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
2015 Standout
Treatment options in severe fungal asthma and allergic bronchopulmonary aspergillosis
2013
Salmonella typhi uses CFTR to enter intestinal epithelial cells
1998 StandoutNatureNobel
Diverse Viruses Require the Calcium Transporter SPCA1 for Maturation and Spread
2017 StandoutNobel
Approaches to the simultaneous inactivation of metallo- and serine-β-lactamases
2009
Antimicrobial resistance in the respiratory microbiota of people with cystic fibrosis
2014
What Is Wrong with Pertussis Vaccine Immunity?
2017
Complex Molecular Epidemiology of Methicillin-Resistant Staphylococcus aureus Isolates From Children With Cystic Fibrosis in the Era of Epidemic Community-Associated Methicillin-Resistant S aureus
2008
Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues
2008 Standout
Cystic fibrosis genetics: from molecular understanding to clinical application
2014 Standout
Electroporation enhances immune responses and protection induced by a bovine viral diarrhea virus DNA vaccine in newborn calves with maternal antibodies
2010
Why is the cystic fibrosis gene so frequent?
1989
Sickle-cell disease
2010 Standout
Urban wastewater treatment plants as hotspots for antibiotic resistant bacteria and genes spread into the environment: A review
2013 Standout
Cystic Fibrosis Pulmonary Guidelines
2013
Recent developments in pertussis
2006
Virus target cell conditioning model to explain some epidemiologic characteristics of childhood leukemias and lymphomas
2005 StandoutNobel
Use of the paediatric bronchoscope, flexible and rigid, in 51 European centres
1997
Glucocorticoid resistance in inflammatory diseases
2009
Airway Mucus Function and Dysfunction
2010 Standout
Protected specimen brush or bronchoalveolar lavage to diagnose bacterial nosocomial pneumonia in ventilated adults: A meta-analysis
1999
Randomized Trial of Peanut Consumption in Infants at Risk for Peanut Allergy
2015 Standout
How should an incident case of atopic dermatitis be defined? A systematic review of primary prevention studies
2012
Palivizumab immunoprophylaxis effectiveness in children with cystic fibrosis
2012
Coexisting Endogenous Lipoid Pneumonia, Cholesterol Granulomas, And Pulmonary Alveolar Proteinosis in a pediatric Population: A Clinical, Radiographic, and Pathologic Correlation
1992
Cystic fibrosis-related bone disease
2013
Bronchoalveolar lavage studies in children without parenchymal lung disease: Cellular constituents and protein levels
1995
Cystic fibrosis
2009
Treatment of lung infection in patients with cystic fibrosis: Current and future strategies
2012
A review of palivizumab and emerging therapies for respiratory syncytial virus
2011
Ventilator-associated Pneumonia
2002 Standout
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
2003 Standout
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Factors Influencing Acquisition of Burkholderia cepacia Complex Organisms in Patients with Cystic Fibrosis
2013
Acinetobacter baumannii : Emergence of a Successful Pathogen
2008 Standout
Mobile Genetic Elements Associated with Antimicrobial Resistance
2018 Standout
Systematic review of treatments for atopic eczema.
2000
Practical Guidelines: Lung Transplantation in Patients with Cystic Fibrosis
2014
Chest physiotherapy compared to no chest physiotherapy for cystic fibrosis
2015
The Accessory Genome of Pseudomonas aeruginosa
2010
Bronchoalveolar lavage in children. ERS Task Force on bronchoalveolar lavage in children. European Respiratory Society
2000 Standout
The complex interplay of iron, biofilm formation, and mucoidy affecting antimicrobial resistance ofPseudomonas aeruginosa
2014
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
Clinical Practice Guideline: The Diagnosis, Management, and Prevention of Bronchiolitis
2014 Standout
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Dietary products used in infants for treatment and prevention of food allergy.. Joint statement of the European Society for Paediatric Allergology and Clinical Immunology (ESPACI) Committee on Hypoallergenic Formulas and the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) Committee on Nutrition
1999
Three Decades of β-Lactamase Inhibitors
2010 Standout
Interventions for the eradication of meticillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis
2015
Interplay among Resistance Profiles, High-Risk Clones, and Virulence in the Caenorhabditis elegansPseudomonas aeruginosa Infection Model
2017
Exosomes with Immune Modulatory Features Are Present in Human Breast Milk
2007 Standout
Identification of simple arylfluorosulfates as potent agents against resistant bacteria
2021 StandoutNobel
Antibiotic Management of Methicillin-Resistant Staphylococcus aureus–Associated Acute Pulmonary Exacerbations in Cystic Fibrosis
2015
Nebulised hypertonic saline for cystic fibrosis
2018
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Critique of trials in allergic bronchopulmonary aspergillosis and fungal allergy
2006
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
2008 Standout
Comparison of Isolation Media for Recovery of Burkholderia cepacia Complex from Respiratory Secretions of Patients with Cystic Fibrosis
1999
Cystic fibrosis: An update for clinicians. Part 1: Nutrition and gastrointestinal complications
2014
Inactivation of the miR-183/96/182 Cluster Decreases the Severity of Pseudomonas aeruginosa -Induced Keratitis
2016
Synthetic Riboswitches That Induce Gene Expression in Diverse Bacterial Species
2010 StandoutNobel
Pulmonary fat embolism: a distinct cause of severe acute chest syndrome in sickle cell anemia
1994
Origins and Evolution of Antibiotic Resistance
2010 Standout
Community-Associated Methicillin-ResistantStaphylococcus aureus: Epidemiology and Clinical Consequences of an Emerging Epidemic
2010 Standout
The oral microbiota: dynamic communities and host interactions
2018 Standout
Deciphering the Resistome of the Widespread Pseudomonas aeruginosa Sequence Type 175 International High-Risk Clone through Whole-Genome Sequencing
2016
Primary prevention of food allergy in children and adults: systematic review
2014
Lung Infections Associated with Cystic Fibrosis
2002 Standout
Antimicrobial Resistance in ESKAPE Pathogens
2020 Standout
Integrating mechanisms of pulmonary fibrosis
2011 Standout

Works of Anne Malfroot being referenced

Corticosteroids in primary tuberculosis with bronchial obstruction.
1990
Haplotypes in cystic fibrosis patients with or without pancreatic insufficiency from four European populations
1989
Gastroesophageal Reflux: A Primary Defect in Cystic Fibrosis?
1988
Travelling with cystic fibrosis: Recommendations for patients and care team members
2010
Epidemiology ofBurkholderia cepaciacomplex colonisation in cystic fibrosis patients
2004
Lung clearance index in adult cystic fibrosis patients: the role of convection-dependent lung units
2012
Unusual ventilation-perfusion mismatch in partial anomalous venous return
1988
National survey of molecular epidemiology of Staphylococcus aureus colonization in Belgian cystic fibrosis patients
2007
Effect of Systemic Inflammation on Inspiratory and Limb Muscle Strength and Bulk in Cystic Fibrosis
2009
Pseudomonas aeruginosa in the home environment of newly infected cystic fibrosis patients
2007
Burkholderia (Pseudomonas) Cepaciaand Cystic Fibrosis: the Epidemiology in Belgium
1996
Eradication of chronic methicillin-resistant Staphylococcus aureus infection in cystic fibrosis patients. An observational prospective cohort study of 11 patients
2013
Differential cytology of bronchoalveolar lavage fluid in asthmatic children
2003
The long-term effect of a partial whey hydrolysate formula on the prophylaxis of atopic disease
1995
Bilateral fiberoptic bronchoalveolar lavage in acute unilateral lobar pneumonia
1993
Comparative bone status assessment by dual energy X-ray absorptiometry, peripheral quantitative computed tomography and quantitative ultrasound in adolescents and young adults with cystic fibrosis
2011
Prevalence and impact on FEV1 decline of chronic methicillin-resistant Staphylococcus aureus (MRSA) colonization in patients with Cystic Fibrosis
2011
Chest Physiotherapy in Cystic Fibrosis: Short-Term Effects of Autogenic Drainage Preceded by Wet Inhalation of Saline versus Autogenic Drainage Preceded by Intrapulmonary Percussive Ventilation with Saline
2007
Inhaled budesonide induced Cushing's syndrome in cystic fibrosis patients, due to drug inhibition of cytochrome P450
2003
Early referral to cystic fibrosis specialist centre impacts on respiratory outcome
2008
Gastroesophageal reflux and unexplained chronic respiratory disease in infants and children
1987
Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium
2007
Dose-finding and 24-h monitoring for efficacy and safety of aerosolized Nacystelyn in cystic fibrosis
2002
Molecular Typing of Bordetella pertussis Isolates Recovered from Belgian Children and Their Household Members
2003
Therapeutic bronchoscopy in ventilated neonates.
1993
Do inhaled corticosteroids impair long-term growth in prepubertal cystic fibrosis patients?
2006
Immunisation in the current management of cystic fibrosis patients
2005
A Serine to proline substitution (S1255P) in the second nucleotide binding fold of the cystic fibrosis gene
1992
Rapidly developing Cushing syndrome in a 4-year-old patient during combined treatment with itraconazole and inhaled budesonide
2003
New insights on gastro-oesophageal reflux in cystic fibrosis by longitudinal follow up.
1991
Is bronchoalveolar lavage safe in acute airway infection in children
1995
Characteristics of Gastroesophageal Reflux and Potential Risk of Gastric Content Aspiration in Children With Cystic Fibrosis
2010
Prevalence and impact on FEV1 decline of methicillin-resistant Staphylococcus aureus infection in patients with cystic fibrosis
2011
Influence of inhaled hypertonic saline combined with airway clearance on SpO2 heart rate dyspnoea and wet sputum weight in hospitalised CF patients
2008
Effect of Shear Stress on Pseudomonas aeruginosa Isolated from the Cystic Fibrosis Lung
2016
Ferrous Iron Is a Significant Component of Bioavailable Iron in Cystic Fibrosis Airways
2013
Treatment of Infants and Toddlers With Cystic Fibrosis–related Pancreatic Insufficiency and Fat Malabsorption With Pancrelipase MT
2011
244* Influence of inhaled hypertonic saline (NaCI 6%) before or during autogenic drainage on sputum weight, oxygen saturation, heart frequency and dyspnoea in cystic fibrosis patients
2011
Bordetella pertussis Infection in 2-Month-Old Infants Promotes Type 1 T Cell Responses
2003
SUPPURATIVE THROMBOPHLEBITIS WITH SEPSIS DUE TO CANDIDA ALBICANS
1986
Rankless by CCL
2026